Savient Pharmaceuticals Inc (SVNT) Inventory Turnover Ratio, from third quarter 2013 to third quarter 2012, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Savient Pharmaceuticals Inc  (SVNT)
 

Savient Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Savient Pharmaceuticals Inc inventory turnover ratio, the Savient Pharmaceuticals Inc's ability to sell and replace its inventory in the third quarter 2013, sequentially increased to 7.01 in the third quarter 2013, a new company high. Average inventory processing period, for the Savient Pharmaceuticals Inc in Sep 30 2013 quarter, has decreased to 52 days, compare to 89 days, in the Jun 30 2013 quarter.

Within Healthcare sector 38 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 415 in the second quarter 2013, to 667.

SVNT Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Savient Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SVNT Inventory Turnover Ratio (Sep 30 2013)
III. Quarter		 (Jun 30 2013)
II. Quarter		 (Mar 31 2013)
I. Quarter		 (Dec 31 2012)
IV. Quarter		 (Sep 30 2012)
III. Quarter
Y / Y Inventory Growth -88.18 % -84.72 % -78.95 % -60.41 % 33.33 %
Y / Y Cost of Sales Growth -66.39 % -69.7 % 106.4 % - -7.9 %
Inventory Turnover Ratio (TTM) 7.01 4.12 3.5 2.45 1.17
SVNT's Total Ranking # 667 # 415 # 504 # 556 #
Average inventory processing period 52 89 104 149 311
Seq. Inventory Growth -19.94 % -33.85 % -44.95 % -59.47 % 3.56 %
Seq. Cost of Sales Growth -30.37 % -42.59 % -63.45 % 130.06 % -37.24 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 4
Healthcare Sector # 39
Overall Market # 667

Inventory Turnover Ratio Statistics
High Average Low
7.01 2.24 0.43
(Sep 30 2013)   (Jun 30 2011)



SVNT Company Profile >> Back to SVNT Efficiency Comparisons >> Compare SVNT Inventory Turnover Ratio to its Competitors

Financial Statements
Savient Pharmaceuticals Inc's Inventories $ 1 Millions Visit SVNT's Balance sheet
Savient Pharmaceuticals Inc's Cost of Revenues TTM $ 17 Millions Visit SVNT's Income Statement
What are SVNT's Sales? Visit SVNT's Sales by Segment

Other Inventory Turnover Ratios
Savient Pharmaceuticals Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
SVNT's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for SVNT's Competitors
Inventory Turnover Ratio for SVNT's Suppliers
Inventory Turnover Ratio for SVNT's Customers

You may also want to know
SVNT's Sales Growth Rates SVNT's Pe Price to earnings ratio SVNT's Receivables Turnover Ratio SVNT's Stock Quote
SVNT's Net Income Growth Rates SVNT's Ps Price to Sales ratio SVNT's Sales per Employee SVNT's Asset Turnover Ratio
SVNT's Net Margin SVNT's Pb Price to Book ratio SVNT's Financial Strength Ratios SVNT's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2013, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2013 Inventories at quarter ending Sep 30 2013
Healthcare Services Group Inc   33.12 $ 964.588  Millions$ 29  Millions
Labcorp Holdings Inc   28.45 $ 3,541.500  Millions$ 124  Millions
Cryoport inc   28.01 $ 1.310  Millions$ 0  Millions
Lisata Therapeutics Inc   25.45 $ 20.459  Millions$ 1  Millions
Musclepharm Corporation  21.70 $ 62.282  Millions$ 3  Millions
Zeo Scientifix Inc   20.49 $ 0.283  Millions$ 0  Millions
Clearday Inc   18.93 $ 1.869  Millions$ 0  Millions
Option Care Health Inc   18.46 $ 522.097  Millions$ 28  Millions
China Yct International Group, Inc.  16.93 $ 34.287  Millions$ 2  Millions
Fibrocell Science, Inc.  16.58 $ 8.909  Millions$ 1  Millions
Rockwell Medical inc   16.05 $ 45.113  Millions$ 3  Millions
Insulet Corporation  14.86 $ 131.677  Millions$ 9  Millions
Igc Pharma Inc   14.81 $ 6.331  Millions$ 0  Millions
Strata Skin Sciences Inc  13.03 $ 5.409  Millions$ 0  Millions
Lineage Cell Therapeutics Inc   12.86 $ 0.751  Millions$ 0  Millions
Fonar Corporation  12.00 $ 26.883  Millions$ 2  Millions
Bohai Pharmaceuticals Group, Inc.  11.62 $ 40.312  Millions$ 3  Millions
China Pediatric Pharmaceuticals, Inc.  11.20 $ 2.291  Millions$ 0  Millions
Charles River Laboratories International inc   10.93 $ 953.227  Millions$ 87  Millions
Perspective Therapeutics Inc   10.77 $ 4.426  Millions$ 0  Millions
Align Technology inc   10.28 $ 156.646  Millions$ 15  Millions
Amarin Corp Plcuk  10.13 $ 7.813  Millions$ 1  Millions
Tenet Healthcare Corp  10.09 $ 1,546.000  Millions$ 153  Millions
Cerevel Therapeutics Holdings Inc   9.74 $ 6.246  Millions$ 1  Millions
Dyne Therapeutics Inc   9.73 $ 1,095.000  Millions$ 113  Millions
Ufp Technologies Inc   9.53 $ 97.749  Millions$ 10  Millions
Vertex Pharmaceuticals Inc  9.21 $ 195.728  Millions$ 21  Millions
Bioxytran Inc   9.14 $ 0.121  Millions$ 0  Millions
Antares Pharma Inc   9.00 $ 10.214  Millions$ 1  Millions
Biolife Solutions Inc   8.76 $ 5.114  Millions$ 1  Millions

Date modified: 2026-09-02T17:38:16+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.